Net profit of Indo US Bio-Tech rose 168.61% to Rs 3.68 crore in the quarter ended December 2023 as against Rs 1.37 crore during the previous quarter ended December 2022. Sales rose 42.65% to Rs 22.11 crore in the quarter ended December 2023 as against Rs 15.50 crore during the previous quarter ended December 2022.